ISO 13485:2016 certified · Startup India (DPIIT) recognised · NVIDIA Inception program member +91 44 4690 0555info@medoqi.tech
Latin America · Mexico

Obtain a COFEPRIS sanitary registration, using equivalency routes where you qualify.

Classification, registration and equivalency pathways for devices already approved in reference markets, with a Mexican registration holder.

Discuss your Mexican market entry →Last reviewed October 2026
Regulatory overview

Key facts

AuthorityFederal Commission for the Protection against Sanitary Risks (COFEPRIS)
LegislationGeneral Health Law; Health Supplies Regulation; NOM-241-SSA1 (GMP), NOM-137-SSA1 (labelling), NOM-240-SSA1 (technovigilance)
Device classesClass I, II, III
IVD classesDiagnostic agents, Class I to III
Quality systemNOM-241-SSA1 GMP or accepted certificates
Local representationMexican registration holder
Market authorisation

Pathways

  • Sanitary registration (registro sanitario) for most devices
  • Equivalency routes for devices approved by the US FDA, Health Canada or Japan's MHLW
  • Low-risk products listed by COFEPRIS as not requiring registration
Documentation

What you will need

  • Technical and scientific information on the device
  • Evidence of GMP or ISO 13485
  • Spanish-language labelling per NOM-137
  • Reference market approvals for equivalency routes
Registration process

Sequence and decision points

  1. 01ClassifyApply COFEPRIS classification.
  2. 02Appoint a holderA Mexican registration holder.
  3. 03Choose the routeStandard or equivalency route.
  4. 04SubmitDossier to COFEPRIS with fees.
  5. 05Register and monitorRegistration, technovigilance and renewal.
Quality system

GMP per NOM-241-SSA1, shown by inspection or, in some routes, by accepted certificates such as ISO 13485.

Local representation

A Mexican registration holder with the appropriate sanitary notice or licence holds the registration.

Where MedoQi does not hold this role, we work with your appointed representative or a qualified partner.

Timelines and fees

COFEPRIS fees and review periods vary by route; equivalency routes are usually faster.

Post-market obligations

After market entry

  • Technovigilance per NOM-240-SSA1
  • Registration renewal every five years
  • Change notifications
MedoQi services

How we help

  • Classification and route strategy
  • Equivalency route assessment
  • Dossier preparation support
  • Holder coordination
  • Technovigilance support

Delivered through our model: assess, validate, remediate, submit, maintain. How we work

FAQ

Common questions about Mexico

Summary information for orientation. Requirements depend on intended use, classification and device characteristics, and change over time.

Can our FDA clearance speed up Mexican registration?

Often, yes. COFEPRIS equivalency routes recognise approvals from the US FDA, Health Canada and Japan, subject to conditions.

Talk to our experts

Discuss your device, market or audit with a specialist

Share the device, its class and your target markets. A senior specialist will come back with the likely pathway, the evidence gaps we see and a practical plan.

Talk to our experts → Request an AI pilot sales@medoqi.tech · +91 44 4690 0555